Dose delivery characteristics of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004
Inspiratory profiles and resistance of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004
Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012
In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Peak inspiratory flow in COPD: implications for the use of dry powder inhalers Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)? Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Improving inhalation parameters through dry powder inhalers (DPIs) after an acute asthma exacerbation Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Assessment of peak inspiratory flow through dry powder inhalers in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Handling and patient preference of dry powder inhalers for asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Peak inspiratory flow rates in COPD patients with Easyhaler® dry powder inhaler Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Systemic availability (lung deposition) of drug from two different dry powder inhalers in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers Source: Eur Respir J 2001; 18: 780-783 Year: 2001
Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs) Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Inspiratory flow profiles of patients with severe COPD achieved through Autohaler, Diskus, Turbohaler and in vitro assessment of corresponding output characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003
Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001
Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001
In vitro testing of two budesonide dry powder inhalers at different flow ratesSource: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001